Skip to main content
. Author manuscript; available in PMC: 2014 Oct 15.
Published in final edited form as: Nutr Cancer. 2013 Oct 15;65(8):1232–1244. doi: 10.1080/01635581.2013.832779

Figure 2. Ellagic acid and embelin dose-dependently inhibit proliferation in pancreatic cancer cells.

Figure 2

MIA PaCa-2 (A, B) and HPAF-II (C, D) pancreatic cancer cells were cultured for 72h in the presence of indicated doses of embelin or ellagic acid. Proliferation was assessed by measuring 3H-thymidine incorporation into DNA. P-values are for one-sided one-sample t-tests comparing with controls (100 for A and B, 1 for C and D). With Bonferroni’s adjustment, p<0.01 are considered as significant for A and B, p<0.0125 are considered as significant for C and D.